Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
Recruiting · NCT06121505 · Registry updated 2025-12-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer | squamous cell lung carcinoma | Recruiting | Phase 2 | 2025-12-17 | NCT06121505 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
| Sichuan University | 55 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Hospital of North Sichuan Medical College | Nanchong | China | 1 |
| Guizhou Provincial People's Hospital | Guiyang | China | 24 |
| Sichuan Cancer Hospital | Chengdu | China | 2 |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing | China | 17 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 1 |
| West China Hospital of Sichuan University | Chengdu | China | 17 |